UK
Uta Kellermann Renton
About Uta Kellermann Renton
Data last updated:
Uta Kellermann Renton is an Additional Director at Apotex Research Private Limited (since 2025) and Director at Apotex Pharmachem India Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹869 Cr; the largest is Apotex Research Private Limited at ₹727 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 18 Mar 2025 | 2003 | ₹727 Cr (FY 2025) | Active | |
| Director | 23 Sep 2025 | 2003 | ₹142 Cr (FY 2024) | Active |
Board colleagues of Uta Kellermann Renton
| Name | DIN | Company | Designation |
|---|---|---|---|
| Brian George Mcclelland | 06568789 | Apotex Research Private Limited , Apotex Pharmachem India Private Limited | Director |
| Goutam Vilas Pujari | 02891339 | Apotex Research Private Limited | Director |
| Rajesh Salwan | 07669286 | Apotex Research Private Limited | Additional Director |
| Shama Shridhar Doddawad | Apotex Research Private Limited | Cfo | |
| Kajal Palan | 10546962 | Apotex Pharmachem India Private Limited | Additional Director |
| Yoganjaneya Reddy Panem | 02073863 | Apotex Pharmachem India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Uta Kellermann Renton
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Uta Kellermann Renton
Uta Kellermann Renton currently holds 2 directorships: Apotex Research Private Limited (Additional Director, since 18 Mar 2025, revenue ₹727 Cr (FY 2025)); Apotex Pharmachem India Private Limited (Director, since 23 Sep 2025, revenue ₹142 Cr (FY 2024)).
Uta Kellermann Renton was first appointed on 18 Mar 2025 as Additional Director at Apotex Research Private Limited.
The 2 current companies of Uta Kellermann Renton that report revenue have a combined latest revenue of ₹869 Cr: Apotex Research Private Limited ₹727 Cr (FY 2025); Apotex Pharmachem India Private Limited ₹142 Cr (FY 2024).
The current boards of Uta Kellermann Renton's companies include Brian George Mcclelland (Apotex Research Private Limited), Goutam Vilas Pujari (Apotex Research Private Limited), Rajesh Salwan (Apotex Research Private Limited), Shama Shridhar Doddawad (Apotex Research Private Limited), Kajal Palan (Apotex Pharmachem India Private Limited), Yoganjaneya Reddy Panem (Apotex Pharmachem India Private Limited).